Research Focus

Former Employee. Graduate Staff; Fellow

Recent additions – View all

1. Arsenic trioxide (As(2)O(3)): A dose-ranging and clinical pharmacologic study in patients with advanced hematologic cancers

   Meeting Abstract

   Soignet, S. L.; Novick, S.; Bienvenu, B.; Chanel, S.; Ho, R.; Spriggs, D.; Ellison, R.; Warrell, R. P. Jr
   Proceedings of the American Association for Cancer Research Annual Meeting (2000)

   Fulltext@MSK | Save
2. Phase I and pharmacology study of the epothilone B analog BMS-247550 in patients with advanced cancer

   Meeting Abstract

   Spriggs, D.; Soignet, S.; Bienvenu, B.; Letrent, S.; Lebwohl, D.; Burris, H.
   Clinical Cancer Research (2000)

   Fulltext@MSK | Save
3. Pharmacokinetics of arsenic trioxide (ATO) in patients with relapsed/refractory acute promyelocytic leukemia (APL)

   Meeting Abstract

   Soignet, S.; Bienvenu, B.; Warrell, R. P.; Ellisson, R.; Spriggs, D.; Brannan, M.
   Clinical Cancer Research (2000)

   Fulltext@MSK | Save